Breaking News Instant updates and real-time market news.

AMGN

Amgen

$166.90

-0.34 (-0.20%)

10:25
10/07/16
10/07
10:25
10/07/16
10:25

Amgen participates in a conference call with Citigroup

Citigroup Biotech Analyst Karnauskas, along with Amgen's Executive Vice President Harper, hold a Research & Development conference call on October 7 at 11 am. Webcast Link

  • 07

    Oct

  • 07

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Jul

AMGN Amgen
$166.90

-0.34 (-0.20%)

09/29/16
PIPR
09/29/16
NO CHANGE
Target $10
PIPR
Overweight
Arrowhead price target raised to $10 from $8 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Arrowhead Pharmaceuticals (ARWR) to $10 after the company licensed two preclinical cardiovascular RNAi drugs with Amgen (AMGN). Amgen is the "ideal partner" and Arrowhead's balance sheet is now "meaningfully" strengthened, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Arrowhead.
09/27/16
PIPR
09/27/16
NO CHANGE
PIPR
Overweight
Amgen's Kyprolis in good shape despite trial miss, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Amgen's Kyprolis is still likely to be viewed as a "potent backbone, with the right drugs" after a Phase 3 study in front-line myeloma failed to reach its primary endpoint. The analyst believes the impact of the failed trial on Kyprolis use will be limited and he reiterates an Overweight rating on Amgen.
09/27/16
GSCO
09/27/16
NO CHANGE
Target $206
GSCO
Conviction Buy
Goldman surprised by Amgen's Kyprolis outcome in first-line multiple myeloma
Last night, Amgen announced Phase 3 Kypolis CLARION study did not meet the primary endpoint in first-line multiple myeloma. Goldman analyst Terence Flynn was surprised by this outcome given the prior positive superiority data for Kyprolis versus Velcade in the Phase III ENDEAVOR trial. Flynn sees risk to his Kyprolis $1B sales estimate in a first-line setting, but awaits for additional details from the call and further information regarding another ongoing Phase III trial. He expects Amgen shares to be weak on the news but said the company has additional drivers beyond Kyprolis including Repatha for high cholesterol and Erenumab for migraine with additional data expected in 2H 2016 and Q1 2017. Flynn remains Conviction Buy rated on Amgen and maintains his $206 price target.
09/01/16
09/01/16
NO CHANGE

Amgen's sBLA for Blincyto approved by FDA
Amgen's supplemental Biologics License Application for Blincyto has been approved by the FDA to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. This indication is approved under accelerated approval, and continued approval may be contingent upon verification of clinical benefit in subsequent trials. The approval is based on results from the Phase 1/2 '205, an open-label, multicenter, single-arm trial, which evaluated the efficacy and safety of BLINCYTO in pediatric patients with relapsed or refractory B-cell precursor ALL. Blincyto was granted breakthrough therapy, priority review and orphan drug designations by FDA, and is now approved in the U.S. for the treatment of Ph- relapsed or refractory B-cell precursor ALL. In November 2015, BLINCYTO was granted conditional marketing authorization in the European Union for the treatment of adults with Ph- relapsed or refractory B-cell precursor ALL.

TODAY'S FREE FLY STORIES

NUE

Nucor

$62.83

1.97 (3.24%)

15:46
02/27/17
02/27
15:46
02/27/17
15:46
Options
Nucor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKA

Roka Bioscience

$4.26

-0.18 (-4.05%)

15:44
02/27/17
02/27
15:44
02/27/17
15:44
Conference/Events
Roka Bioscience to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 29

    Mar

TESS

TESSCO

$14.05

-0.3 (-2.09%)

15:43
02/27/17
02/27
15:43
02/27/17
15:43
Hot Stocks
TESSCO signs deal with GEAR4 as exclusive U.S. distributor »

TESSCO Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$19.87

1.65 (9.06%)

15:42
02/27/17
02/27
15:42
02/27/17
15:42
Recommendations
La Jolla analyst commentary  »

La Jolla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 19

    Mar

CUR

Neuralstem

$3.86

0.16 (4.32%)

15:36
02/27/17
02/27
15:36
02/27/17
15:36
Hot Stocks
Breaking Hot Stocks news story on Neuralstem »

Tianjin Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WUBA

58.com

$32.46

0.49 (1.53%)

15:35
02/27/17
02/27
15:35
02/27/17
15:35
Options
58.com options imply 10.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NURO

NeuroMetrix

$0.63

-0.0317 (-4.79%)

15:35
02/27/17
02/27
15:35
02/27/17
15:35
Conference/Events
NeuroMetrix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CGI

Celadon Group

$8.55

0.45 (5.56%)

, USAK

USA Truck

$9.00

0.14 (1.58%)

15:33
02/27/17
02/27
15:33
02/27/17
15:33
Hot Stocks
Celadon, USA Truck called best M&A targets as truckers seen consolidating »

Stephens argued that amid…

CGI

Celadon Group

$8.55

0.45 (5.56%)

USAK

USA Truck

$9.00

0.14 (1.58%)

HTLD

Heartland Express

$20.64

0.2 (0.98%)

KNX

Knight Transportation

$32.70

0.55 (1.71%)

SWFT

Swift Transportation

$22.09

0.35 (1.61%)

CVTI

Covenant Transportation

$20.06

0.05 (0.25%)

MRTN

Marten Transport

WERN

Werner

$27.80

0.45 (1.65%)

XPO

XPO Logistics

$51.41

1.01 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 02

    May

GLD

SPDR Gold Trust

$119.45

-0.25 (-0.21%)

15:32
02/27/17
02/27
15:32
02/27/17
15:32
Options
Aggressive short-term call spread in the SPDR Gold Fund »

Aggressive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGY

Stone Energy

$6.73

0.15 (2.28%)

, EQT

EQT Corporation

$60.73

0.785 (1.31%)

15:31
02/27/17
02/27
15:31
02/27/17
15:31
Hot Stocks
Stone Energy announces close of sale of Appalachia properties »

Stone Energy (SGY)…

SGY

Stone Energy

$6.73

0.15 (2.28%)

EQT

EQT Corporation

$60.73

0.785 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXEL

Exelixis

$21.69

-0.05 (-0.23%)

15:20
02/27/17
02/27
15:20
02/27/17
15:20
Options
Exelixis options imply 12.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

$NSD

NASDAQ Market Internals

15:17
02/27/17
02/27
15:17
02/27/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
02/27/17
02/27
15:16
02/27/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$29.94

-0.25 (-0.83%)

15:14
02/27/17
02/27
15:14
02/27/17
15:14
Periodicals
GE sales process for Industrial Solutions may start in March, Bloomberg says »

Amid its continuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

VIP

VimpelCom

$4.30

-0.04 (-0.92%)

15:11
02/27/17
02/27
15:11
02/27/17
15:11
Options
Higher option volume in Vimpel driven by poste-earnings puts »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAC

Marriott Vacations

$96.51

-2.39 (-2.42%)

15:09
02/27/17
02/27
15:09
02/27/17
15:09
Conference/Events
Marriott Vacations management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TGT

Target

$66.95

0.435 (0.65%)

, AZO

AutoZone

$734.44

1.685 (0.23%)

15:06
02/27/17
02/27
15:06
02/27/17
15:06
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TGT

Target

$66.95

0.435 (0.65%)

AZO

AutoZone

$734.44

1.685 (0.23%)

DPZ

Domino's Pizza

$185.90

-0.378 (-0.20%)

VRX

Valeant

$16.73

0.5499 (3.40%)

PAH

Platform Specialty Products

$13.19

0.14 (1.07%)

ENDP

Endo

$13.15

-0.24 (-1.79%)

DDD

3D Systems

$17.04

0.55 (3.34%)

SEAS

SeaWorld

$18.66

0.035 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

PCLN

Priceline

$1,631.62

-5.64 (-0.34%)

, WDAY

Workday

$90.92

1.26 (1.41%)

15:05
02/27/17
02/27
15:05
02/27/17
15:05
Earnings
Notable companies reporting after market close »

Notable companies…

PCLN

Priceline

$1,631.62

-5.64 (-0.34%)

WDAY

Workday

$90.92

1.26 (1.41%)

PRGO

Perrigo

$84.39

-0.04 (-0.05%)

ALB

Albemarle

$92.74

-0.19 (-0.20%)

EXEL

Exelixis

$21.69

-0.05 (-0.23%)

RSPP

RSP Permian

$40.77

0.88 (2.21%)

FTR

Frontier Communications

$3.37

-0.02 (-0.59%)

CST

CST Brands

$48.37

0.02 (0.04%)

THC

Tenet

$22.36

0.365 (1.66%)

HTZ

Hertz

$19.86

-0.11 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

  • 16

    Mar

  • 20

    Mar

  • 21

    Mar

HTZ

Hertz

$19.87

-0.105 (-0.53%)

15:05
02/27/17
02/27
15:05
02/27/17
15:05
Options
Hertz options imply 18.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

15:00
02/27/17
02/27
15:00
02/27/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

MNK

Mallinckrodt

$54.42

1.04 (1.95%)

14:57
02/27/17
02/27
14:57
02/27/17
14:57
Conference/Events
Mallinckrodt management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 03

    Mar

INCY

Incyte

$131.21

9.26 (7.59%)

, SE

Acquired by ENB

14:55
02/27/17
02/27
14:55
02/27/17
14:55
Hot Stocks
Incyte to replace Spectra Energy in S&P 500 as of 2/28 open »

Spectra Energy (SE) is…

INCY

Incyte

$131.21

9.26 (7.59%)

SE

Acquired by ENB

ENB

Enbridge

$42.05

0.705 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 01

    Apr

  • 19

    Apr

DDS

Dillard's

$56.99

-0.01 (-0.02%)

, ISIL

Intersil

14:55
02/27/17
02/27
14:55
02/27/17
14:55
Hot Stocks
Dillard's to replace Intersil in S&P 400 as of 2/28 open »

Renesas Electronics Corp.…

DDS

Dillard's

$56.99

-0.01 (-0.02%)

ISIL

Intersil

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRK

WestRock

$53.69

0.26 (0.49%)

14:54
02/27/17
02/27
14:54
02/27/17
14:54
Conference/Events
WestRock management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GIG

GigPeak

$3.10

0.03 (0.98%)

14:52
02/27/17
02/27
14:52
02/27/17
14:52
Hot Stocks
Gardner Lewis reports new 8.6% stake in GigPeak »

Shares of GigPeak spiked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 05

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.